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ABSTRACT
Objective: To identify the length of perioperative fasting among patients submitted 
to gastrointestinal cancer surgeries. Method: Retrospective cohort study, developed 
by consulting the medical records of 128 patients submitted to gastrointestinal cancer 
surgeries. Results: The mean of total length of fasting was 107.6 hours. The total length 
of fasting was significantly associated with the number of symptoms presented before 
(p=0.000) and after the surgery (p=0.007), the length of hospital stay (p=0.000), blood 
transfusion (p=0.013), nasogastric tube (p=0.001) and nasojejunal tube (p=0,003), 
postoperative admission at ICU (p=0.002), postoperative death (p=0.000) and length 
of preoperative fasting (p=0.000). Conclusion: The length of fasting is associated with 
complications that affect the quality of the patients’ postoperative recovery and nurses’ 
work. The nursing team should be alert to this aspect and being responsible for overseeing 
the patients’ interest, should not permit the unnecessary extension of fasting.
DESCRIPTORS
Digestive System Surgical Procedures; Fasting; Perioperative Nursing; Oncology 
Nursing; Digestive System Neoplasms.
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INTRODUCTION
Eating difficulties exists among surgical cancer patients, 
due to physiological factors associated with the disease pro-
cess or the required fasting time for a range of laboratory and 
surgical procedures, which can culminate in malnutrition 
associated with the hospitalization.
Patients with gastrointestinal tumors are predisposed 
to malnutrition related to the hospitalization itself, aspects 
associated with the diagnosis (type of tumor, staging, among 
others) and the treatment (radiotherapy and chemotherapy), 
which compromise their organism’s ability to react to the 
fasting periods, and affect their postoperative recovery and 
prognosis(1). It is known that changes in the nutritional con-
dition compromise the functioning of the immune system, 
increasing the number of healthcare associated infections, 
the hospitalization period and healthcare costs and affecting 
negatively the healing(2).
The literature shows the improvement in postoperative 
recovery and patients’ wellbeing related to the reduction of 
the fasting period by offering a preoperative solution rich 
in carbohydrates, two to three hours before the induction of 
anesthesia, shortened fasting length and an early oral nutri-
tion during the postoperative period. All these initiative are 
linked to The Enhanced Recovery After Surgery (ERAS), a 
project created to optimize the recovery and perioperative 
management of surgical patients, and proposing care ele-
ments in all perioperative period(3-7).
Reducing preoperative fasting time mitigates the postop-
erative insulin resistance(3) and does not seem to be associated 
with complications, such as bronchoaspiration(4) during the 
anesthetic induction, besides it, reduces the hospital staying 
without compromising the quality of patient care(5-7).
Despite this, many hospital institutions keep traditional 
fasting protocols, submitting patients to extended fasting 
times, between eight or 12 hours. This study was interested 
to explore the fasting time period at a cancer hospital.
The aims of the study were to identify the length of pre-
operative fasting and total fasting time in patients submitted 
to gastrointestinal cancer surgeries and verify the relation 
between the length of fasting and the independent variables: 
symptoms, length of stay, blood transfusion, glucose levels, 
nasogastric/nasojejunal tube.
METHOD
We performed a retrospective cohort study by consulting 
the medical records of patients over 18 years old, submit-
ted to gastrointestinal cancer surgeries, between March and 
April 2014, at an oncology hospital located in the State of 
São Paulo (Brazil) that does not apply the ERAS protocol.
Linear regression based on nine predictable variables that 
explain 20% of the variation in the fasting time was used 
to calculate the sample. Thus, the initially proposed sample 
size was 104 patients, adopting a 5% significance and 95% 
power level. The final sample was 128 patients.
Data collection was performed by medical records of patients 
who met the selection criteria between March and April 2014, 
since the surgery admission, until the hospital discharge and 
included sociodemographic variables (sex and age), nutritional 
(weight, height, body mass index – BMI, nasogastric/naso-
jejunal tube), laboratory findings (glucose), gastrointestinal 
symptoms (nausea, vomiting), and variables related to the 
disease and the health treatment (medical diagnosis; presence 
of hypertension and/or diabetes mellitus; previous chemo-
therapy or radiotherapy treatment; preoperative fasting time 
calculated from the last meal time to induction of anesthesia 
and total fasting time during the hospitalization, including 
the preoperative last meal to first solid or liquid intake and 
fasting before laboratorial tests and/or imaging tests; type of 
surgery; need of blood transfusion and length of stay).
The data were analyzed using mean, standard deviation 
(SD), median and range, the Mann-Whitney test, Paired 
T Test, Kruskal-Wallis Test and Pearson’s Correlation. 
Significance level was set at α< 0.05.
Approval for the research project was obtained from the 
Research Ethics Committee, registered number 659.354.
RESULTS
In the study, 128 patients submitted to gastrointestinal 
cancer surgeries were included, 77 (60.2%) of them were 
male and 51 (39.8%) women, with a mean age of 62.1 
years  old (Table 1).
The weight at the hospital admission was registered for 
107 (83.6%) patients, while the weight at the moment of the 
postoperative discharge was present in 36 (28.1%) records 
(Table 1). The mean difference among patients who had the 
measure of weight on admission and discharge was 1.5 Kg. The 
average length of stay was 15.4 days (SD=13.4), the total length 
of fasting was 107.6 hours (SD=73) or 4.5  days (Table 1).
Table 1 – Distribution of patients according to demography and 
hospitalization variables – São Paulo, São Paulo, Brazil, 2014.
Variables n (%) Mean ± SD Median Range
Female 51 (39.8)
Male 77 (60.2)
Age 128 (100) 62.1±13.2 62 19-89
Weight upon 
admission (Kg) 107 (83.6) 67.4±14.3 65.1 42-110
Body mass index 
(Kg/m2) 107 (83.6) 25.2±4.5 25.0 16.4-37.4
Weight upon 
discharge (Kg) 36 (28.1) 68.0±16.8 65.8 41.6-116.4
Length of stay (days) 128 (100) 15.4±13.4 10.5 1-78
Hours of 
preoperative fasting 117 (91.4) 26.4±47.1 12.2 4.0-363.7
Total length of 
fasting (hours) 121 (94.5) 107.6±73.0 88 24-501
Length of surgery 
(minutes) 114 (89.1) 260.1±159.8 220 40-825
Death 20 (15.6)
Note: (n=128)
Forty-nine (38.3%) patients underwent chemotherapy 
(CT), four (3.1%) radiotherapy (RT) and 31 (24.2%) CT 
and RT. The most frequent chemotherapy drug combination 
was oxaliplatin, leucovorin, 5-fluorouracil (n=18; 14.1%).
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The main comorbidity identified was Systemic Arterial 
Hypertension (SAH) in 44 (34.4%) patients and 21 (16.4%) 
had both SAH and Diabetes Mellitus (DM).
Among the patients, eight (6.2%) had their scheduled 
surgeries canceled, due to administrative problems. All of 
them were rescheduled and took place afterwards, during 
the same hospitalization period under analysis.
Preoperative glucose measures were registered in only 
22 (17.2%) medical records, with a mean of 134.4 mg/dl 
(SD=40.8mg/dl), median 123mg/dl, range from 71mg/dl 
to 235mg/dl. Postoperative glucose was registered to 75 
(58.6%) patients, with a mean of 141.8 mg/dl (SD=41.2 
mg/dl), median 138mg/dl, range from 57mg/dl to 275mg/dl.
The most frequent diagnoses were malignant rectal 
cancer (n=40; 31.2%), malignant stomach cancer (n=19; 
4.8%) and malignant colon cancer (n=14; 10.9%). Thus, the 
most common surgeries were rectosigmoidectomy (n=26; 
20.3%), exploratory laparotomy (n=23; 18.0%), and gastrec-
tomy (n=13; 10.1%). Gastrectomy, ileostomy, jejunostomy 
or colostomys were observed in 19 (14.8%) patients. After 
the surgery, 70 (54.7%) patients were forwarded to the ward 
and 58 (45.3%) to the ICU.
At the end of the fasting period, 93 (72.7%) patients 
returned to the oral feeding, and 14 (10.9%) started 
an  enteral diet.
Some symptoms were observed as preoperative nausea 
(n=21; 16.4%), postoperative nausea (n=68; 53.1%), preop-
erative vomiting (n=26; 20.3%) and postoperative vomit-
ing (n=52; 40.6%). The nasogastric tube was present in 60 
(46.9%) patients during the postoperative period.
The preoperative length of fast showed a statistically sig-
nificant association with the length of stay (p=0.002), the 
number of preoperative symptoms (p=0.000), nasogastric tube 
(p=0.014) and the patient’s postoperative death (p=0.015).
The total length of fasting was significantly associated 
with the number of symptoms the patient presented before 
(p=0.000) and after the surgery (p=0.007), the length of stay 
(p=0.000), blood transfusion (p=0.013), nasogastric tube 
(p=0.001), nasojejunal (p=0.003) tube, postoperative ICU 
admission (p=0.002), patient’s postoperative death (p=0.000) 
and preoperative length of fasting (p=0.000).
DISCUSSION
In this study, it was observed that the patients submitted 
to longer length of fasting had more preoperative and post-
operative symptoms, longer hospitalization, postoperative 
ICU admission, as well as postoperative death. In addition, 
the preoperative length of fast determined a longer length 
of total fasting.
The current discussion about the fasting cannot be 
detached from the Brazilian and international projects aimed 
at reducing the complications and influencing the postop-
erative recovery process, through the implementation of a 
multimodal protocol, which includes the reduction in the pre-
operative length of fasting and early reintroduction of food(8).
The projects Enhanced Recovery After Surgery (ERAS) 
and the Brazilian project ACEleração da Recuperação TOtal 
Pós-operatória (ACERTO – Acceleration of Complete 
Postoperative Recovery) intend to optimize the patient’s 
recovery through perioperative care, such as the short-
ening of fasting, restricted use of nasogastric tube and 
drains, early return of the diet in the postoperative period, 
early mobilization(8).
Hence, studies that compared the length of hospitaliza-
tion between patients operated on after the implementation 
of the ERAS protocol and patients operated on before its 
implementation concluded that the period after the start 
of the protocol entailed a shorter hospitalization and post-
operative recovery(9-10). A randomized study also concluded 
that the ERAS protocol mitigates the surgical stress and 
accelerates the recovery, without increasing the morbidity 
and mortality rates(11).
In the same sense, a study on the adherence rate to the 
ERAS protocol found that, during the years of higher com-
pliance levels, the length of hospitalization dropped when 
compared to the low compliance periods. The implementa-
tion of the protocol reduced the fasting periods and contrib-
uted to other aspects that significantly improved the post-
operative evolution, such as the reduction of the nasogastric 
tube use, early oral nutrition and early mobilization(12).
In another study that analyzed a control group that fol-
lowed traditional fasting, being deprived of food and fluids 
and an intervention group that received fluids up to two 
hours before the surgery and solid foods up to six hours, it 
was verified that the intervention group showed less pre-
operative symptoms, such as hunger, headache and nau-
sea, besides signs of feeling more comfortable(13). Another 
prospective study observed that patients who fasted for a 
shorter period had less postoperative symptoms like nausea 
and vomiting(14). These aspects were observed in the present 
study, as patients who fasted longer had more postoperative 
symptoms like nausea and vomiting, for example.
It should also be highlighted that shorter fasting not 
only contributes to reduce the length of hospitalization, 
but entailed the lesser need for blood transfusion, a lesser 
number of cases of surgical site infections, reduction in the 
number of intraoperative complications and deaths(8).
Our study pointed out association between fast-
ing time and need for blood transfusion. It is important 
remember that blood transfusion, among colorectal can-
cer patients, have been associated with increased length of 
stay, morbidity, recurrence of tumor, decreased long term 
survival  and  death(15-17).
Therefore, it can be deduced that, even if fasting is nec-
essary at some time due to the health condition of gas-
trointestinal tumor patients, the excessive extension of this 
fasting time can compromise the recovery, prolongs the 
hospitalization and increases the chances of complications 
and even death.
When analyzing these data from the economic view-
point, shortening the length of fasting contributes to reduce 
costs, due to the greater bed turnover and reduced length of 
hospitalization, and earlier hospital discharge(8).
 The initiative to reduce fasting time is related to a mul-
tidisciplinary approach, including nurse, surgeon, anesthe-
tist and nutritionist(18). A real team work is essential to the 
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success of this intervention and the nurse is the link of team, 
managing and executing all care elements, resulting in a 
fulfillment of protocol. The scientific literature shows that 
the higher compliance to the ERAS is related to a reduced 
length of stay and the nursing workload(19-20).
 It is important to highlight that there are important 
activities of nursing that could be implemented during the 
perioperative period, related to a better quality of life, com-
fort and satisfaction of patients.
Among this measures, preoperative counseling could 
contribute to the reduction of pain, anxiety and complica-
tions, and increase postoperative self-care(21); the prevention 
of hypothermia, nausea and vomiting(22) during the intra-
operative period; to recognize and treat the postoperative 
thirst in the Post Anesthetic Care Unit (PACU) a frequent 
symptom, reaching 100% of patients with more than eight 
hours of fasting, that could be safely treated with 2 ml of 
ice, placed in the patient’s mouth to completely dissolve(23); 
and to encourage oral fluid, feeding and early mobilization 
to prevent blood clots(22) in clinical ward. All this measures 
could be safely implemented in many hospitals, with mini-
mal alterations on institutional policies.
CONCLUSION
In this study, the preoperative length of fasting was sig-
nificantly associated with the length of hospitalization, the 
number of preoperative symptoms, nasogastric tubes and 
death. The total length of fasting was significantly associated 
with the number of symptoms presented before and after 
surgery, the length of stay, blood transfusion, nasogastric 
and nasojejunal tubes, postoperative ICU admission and 
postoperative death.
The scientific literature show us how extended fasting 
periods could reverberate on nursing workload. Therefore, 
the multi-professional team and particularly the nursing 
staff need to discuss this issue. As patient advocate, the 
nurses should watch out for continuously unnecessary fast-
ing period for procedures and diagnostic exams and, even 
when necessary, these fasting periods should be reduced to 
a minimum, aiming to privilege the patient’s recovery.
RESUMO
Objetivo: Identificar o tempo de jejum perioperatório e sua associação a variáveis pós-operatórias entre pacientes submetidos a cirurgias 
oncológicas do trato digestório. Método: Estudo de coorte retrospectiva, realizado por meio da consulta a 128 prontuários de pacientes 
adultos, submetidos a cirurgias oncológicas gastrointestinais. Resultados: O tempo total de jejum durante a internação foi em média 107,6 
horas. O tempo total de jejum foi associado de forma estatisticamente significante ao número de sintomas pré-operatórios (p=0,000) e 
pós-operatórios (p=0,007), ao período de internação (p=0,000), à transfusão sanguínea (p=0,013), ao uso de cateter nasogástrico (p=0,001) 
e nasoentérico (p=0,003), à admissão pós-operatória em terapia intensiva (p=0,002), à morte pós-operatória (p=0,000) e à duração do 
jejum pré-operatório (p=0,000). Conclusão: A duração do jejum é associada a complicações que afetam a qualidade da recuperação do 
paciente e o trabalho da enfermagem. A equipe de enfermagem deve estar atenta a esse aspecto, uma vez que, como responsável pela 
vigilância dos interesses dos pacientes, não deve permitir o prolongamento desnecessário do período de jejum.
DESCRITORES
Procedimentos Cirúrgicos do Aparelho Digestivo; Jejum; Enfermagem Perioperatória; Enfermagem Oncológica; Neoplasias do 
Sistema Digestivo.
RESUMEn
Objetivo: Identificar la duración del ayuno perioperatorio entre los pacientes sometidos a cirugías de cáncer gastrointestinal. 
Método:  Estudio de cohorte retrospectivo, por consulta de los registros médicos de 128 pacientes sometidos a cirugías de cáncer 
gastrointestinal. Resultados: La media de la duración total del ayuno fue de 107,6 horas. La duración total del ayuno se asoció 
significativamente con el número de síntomas presentados antes (p=0,000) y después de la cirugía (p=0,007), la duración de la estancia 
hospitalaria (p=0,000), transfusión de sangre (p=0,013),tubo nasogástrico (P=0,003), ingreso postoperatorio en la UCI (p=0,002), 
muerte postoperatoria (p=0,000) y duración del ayuno preoperatorio (p=0,000). Conclusión: La duración del ayuno se asocia con 
complicaciones que afectan la calidad de la recuperación postoperatoria de los pacientes y el trabajo de enfermería. El equipo de 
enfermería debe estar alerta en relación a este aspecto y ser responsable de supervisar el interés de los pacientes, no permitiendo la 
extensión innecesaria del ayuno.
DESCRIPTORES
Procedimientos Quirúrgicos del Sistema Digestivo; Ayuno; Enfermería Perioperatoria; Enfermería Oncológica; Neoplasias del 
Sistema  Digestivo.
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